These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32467540)

  • 21. Change in glycaemic control with structured diabetes self-management education in urban low-resource settings: multicentre randomised trial of effectiveness.
    Lamptey R; Amoakoh-Coleman M; Barker MM; Iddi S; Hadjiconstantinou M; Davies M; Darko D; Agyepong I; Acheampong F; Commey M; Yawson A; Grobbee DE; Adjei GO; Klipstein-Grobusch K
    BMC Health Serv Res; 2023 Feb; 23(1):199. PubMed ID: 36829179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control.
    Molló À; Berenguera A; Rubinat E; Vlacho B; Mata M; Franch J; Bolíbar B; Mauricio D
    BMC Fam Pract; 2019 Feb; 20(1):25. PubMed ID: 30732583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
    Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
    Trials; 2015 Dec; 16():547. PubMed ID: 26631181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Highly Tailored Text and Voice Messaging Intervention to Improve Medication Adherence in Patients With Either or Both Hypertension and Type 2 Diabetes in a UK Primary Care Setting: Feasibility Randomized Controlled Trial of Clinical Effectiveness.
    Kassavou A; Mirzaei V; Brimicombe J; Edwards S; Massou E; Prevost AT; Griffin S; Sutton S
    J Med Internet Res; 2020 May; 22(5):e16629. PubMed ID: 32427113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.
    Furler J; O'Neal D; Speight J; Manski-Nankervis JA; Gorelik A; Holmes-Truscott E; Ginnivan L; Young D; Best J; ; Patterson E; Liew D; Segal L; May C; Blackberry I
    BMJ; 2017 Mar; 356():j783. PubMed ID: 28274941
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing the cost, glycaemic control and medication adherence of utilizing patients' own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting.
    Lim PC; Chung YY; Tan SJ; Wong TY; Permalu DD; Cheah TK; Lim SL; Lee CY
    Daru; 2021 Jun; 29(1):125-132. PubMed ID: 33538999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes.
    Riddell MA; Dunbar JA; Absetz P; Wolfe R; Li H; Brand M; Aziz Z; Oldenburg B;
    BMC Public Health; 2016 Aug; 16(1):864. PubMed ID: 27558630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study.
    Molló À; Vlacho B; Gratacòs M; Mata-Cases M; Rubinat E; Berenguera Ossó A; Cos FX; Franch-Nadal J; Khunti K; Mauricio D;
    Diabetes Obes Metab; 2023 Dec; 25(12):3549-3559. PubMed ID: 37608473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobile phone intervention for increasing adherence to treatment for type 2 diabetes in an urban area of Bangladesh: protocol for a randomized controlled trial.
    Islam SM; Lechner A; Ferrari U; Froeschl G; Alam DS; Holle R; Seissler J; Niessen LW
    BMC Health Serv Res; 2014 Nov; 14():586. PubMed ID: 25424425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial.
    Rosli MR; Neoh CF; Wu DB; Hassan NW; Mahmud M; Rahimi A; Karuppannan M
    Pharm Pract (Granada); 2021; 19(3):2397. PubMed ID: 34621450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The community-based prevention of diabetes (ComPoD) study: a randomised, waiting list controlled trial of a voluntary sector-led diabetes prevention programme.
    Smith JR; Greaves CJ; Thompson JL; Taylor RS; Jones M; Armstrong R; Moorlock S; Griffin A; Solomon-Moore E; Biddle MSY; Price L; Abraham C
    Int J Behav Nutr Phys Act; 2019 Nov; 16(1):112. PubMed ID: 31771589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
    Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
    BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE).
    REPOSE Study Group
    BMJ; 2017 Mar; 356():j1285. PubMed ID: 28360027
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of Pharmacist-led Educational Intervention on Predictors of Diabetic Foot at Two Different Hospitals of Malaysia.
    Khan AH; Iqbal MZ; Syed Sulaiman SA; Ibrahim A; Azmi NSBY; Iqbal MS; Albassam AA
    J Pharm Bioallied Sci; 2021; 13(1):108-115. PubMed ID: 34084056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
    Michiels Y; Bugnon O; Chicoye A; Dejager S; Moisan C; Allaert FA; Hunault C; Romengas L; Méchin H; Vergès B
    Adv Ther; 2019 Jun; 36(6):1291-1303. PubMed ID: 31049873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient satisfaction and medication adherence assessment amongst patients at the diabetes medication therapy adherence clinic.
    Bakar ZA; Fahrni ML; Khan TM
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S139-43. PubMed ID: 27055354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: A cluster randomised controlled trial.
    Alfian SD; van Boven JFM; Abdulah R; Sukandar H; Denig P; Hak E
    Br J Clin Pharmacol; 2021 Apr; 87(4):2032-2042. PubMed ID: 33085801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study.
    Farmer AJ; Oke J; Hardeman W; Tucker L; Sutton S; Kinmonth AL; Griffin S; Holman RR
    Diabetes Res Clin Pract; 2016 Oct; 120():56-64. PubMed ID: 27522034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a primary care nurse delivered educational intervention for patients with type 2 diabetes mellitus in promoting metabolic control and compliance with long-term therapeutic targets: Randomised controlled trial.
    De la Fuente Coria MC; Cruz-Cobo C; Santi-Cano MJ
    Int J Nurs Stud; 2020 Jan; 101():103417. PubMed ID: 31683226
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.